<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html xmlns:o="urn:schemas-microsoft-com:office:office" __expr-val-dir="ltr" dir="ltr"><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
<meta name="GENERATOR" content="Microsoft SharePoint"/><meta name="progid" content="SharePoint.WebPartPage.Document"/><meta http-equiv="Expires" content="0"/><meta name="ROBOTS" content="NOHTMLINDEX"/><title>
	Proposed Revision | APA DSM-5
</title><link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorCustomStyles.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorTableFormats.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/core.css"/>
<link rel="stylesheet" type="text/css" href="../../Style Library/DSM_Css/DSM.css"/>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/init.js"></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/core.js" defer></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/non_ie.js"></script>
<link type="text/xml" rel="alternate" href="http://www.dsm5.org/ProposedRevisions/_vti_bin/spsdisco.aspx"/>
	<style type="text/css">
		#DSM_MainContent {
			background-color: transparent;
			padding: 0px;
		}			
	</style>
<!--[if gte mso 9]><xml>
<o:CustomDocumentProperties>
<o:PublishingContactPicture msdt:dt="string">, </o:PublishingContactPicture></o:CustomDocumentProperties></xml><![endif]-->
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery-1.3.2.min.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery.easing.1.3.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.min.js"></script><script language="javascript" src="../../Style Library/DSM_js/RevisionTabs.js" type="text/javascript"></script><script language="javascript" src="../../Style Library/DSM_js/search.js" type="text/javascript"></script><style type="text/css">
	.zz1_TopNavigationMenu_0 { background-color:white;visibility:hidden;display:none;position:absolute;left:0px;top:0px; }
	.zz1_TopNavigationMenu_1 { text-decoration:none; }
	.zz1_TopNavigationMenu_2 {  }
	.zz1_TopNavigationMenu_3 { border-style:none; }
	.zz1_TopNavigationMenu_4 {  }
	.zz1_TopNavigationMenu_5 { border-style:none; }
	.zz1_TopNavigationMenu_6 {  }
	.zz1_TopNavigationMenu_7 {  }
	.zz1_TopNavigationMenu_8 { border-style:none; }
	.zz1_TopNavigationMenu_9 {  }
	.zz1_TopNavigationMenu_10 { border-style:none; }
	.zz1_TopNavigationMenu_11 {  }
	.zz1_TopNavigationMenu_12 { border-style:none; }
	.zz1_TopNavigationMenu_13 {  }
	.zz1_TopNavigationMenu_14 { border-style:none; }
	.zz1_TopNavigationMenu_15 { background-color:#CBE3F0; }
	.ctl00_PlaceHolderMain_LeftColZone_0 { border-color:Black;border-width:1px;border-style:Solid; }
	.ctl00_PlaceHolderMain_LoginZone_0 { border-color:Black;border-width:1px;border-style:Solid; }
	.ctl00_PlaceHolderMain_RightColZone_0 { border-color:Black;border-width:1px;border-style:Solid; }
</style></head><body style="background:url(../../Style%20Library/DSM_Images/background.gif) repeat-x;margin:0px;" scroll="yes" onload="javascript:if (typeof(_spBodyOnLoadWrapper) != 'undefined') _spBodyOnLoadWrapper();"><form name="aspnetForm" method="post" action="../../ProposedRevisions/Pages/proposedrevision_rid_574.html" id="aspnetForm">
<input type="hidden" name="MSO_PageHashCode" id="MSO_PageHashCode" value="3895-1381814568"/>
<input type="hidden" name="__SPSCEditMenu" id="__SPSCEditMenu" value="true"/>
<input type="hidden" name="MSOWebPartPage_PostbackSource" id="MSOWebPartPage_PostbackSource" value=""/>
<input type="hidden" name="MSOTlPn_SelectedWpId" id="MSOTlPn_SelectedWpId" value=""/>
<input type="hidden" name="MSOTlPn_View" id="MSOTlPn_View" value="0"/>
<input type="hidden" name="MSOTlPn_ShowSettings" id="MSOTlPn_ShowSettings" value="False"/>
<input type="hidden" name="MSOGallery_SelectedLibrary" id="MSOGallery_SelectedLibrary" value=""/>
<input type="hidden" name="MSOGallery_FilterString" id="MSOGallery_FilterString" value=""/>
<input type="hidden" name="MSOTlPn_Button" id="MSOTlPn_Button" value="none"/>
<input type="hidden" name="__REQUESTDIGEST" id="__REQUESTDIGEST" value="0xCABBB7E988FD803C2C4DB38C19667AD1E18DB47BDBB298E7D31E342FAAF0298708DF633DBF8CE5AD879971C4711D9B3DCFF5F91FD1B4CD35EEFCE45648340585,19 Oct 2012 20:53:03 -0000"/>
<input type="hidden" name="MSOAuthoringConsole_FormContext" id="MSOAuthoringConsole_FormContext" value=""/>
<input type="hidden" name="MSOAC_EditDuringWorkflow" id="MSOAC_EditDuringWorkflow" value=""/>
<input type="hidden" name="MSOSPWebPartManager_DisplayModeName" id="MSOSPWebPartManager_DisplayModeName" value="Browse"/>
<input type="hidden" name="MSOWebPartPage_Shared" id="MSOWebPartPage_Shared" value=""/>
<input type="hidden" name="MSOLayout_LayoutChanges" id="MSOLayout_LayoutChanges" value=""/>
<input type="hidden" name="MSOLayout_InDesignMode" id="MSOLayout_InDesignMode" value=""/>
<input type="hidden" name="MSOSPWebPartManager_OldDisplayModeName" id="MSOSPWebPartManager_OldDisplayModeName" value="Browse"/>
<input type="hidden" name="MSOSPWebPartManager_StartWebPartEditingName" id="MSOSPWebPartManager_StartWebPartEditingName" value="false"/>
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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"/>
<script> var MSOWebPartPageFormName = 'aspnetForm';</script>
<script type="text/javascript">
//<![CDATA[
                function DoCallBack(filterText)
                {
                    WebForm_DoCallback('ctl00$m$g_3f2d429f_e45d_4299_8ebf_e8597f5fcbab',filterText,UpdateFilterCallback,0,CallBackError,true);
                }
                function CallBackError(result, clientsideString)
                {                
                }
            //]]>
</script>
<script type="text/JavaScript" language="JavaScript">
<!--
var L_Menu_BaseUrl="/ProposedRevisions";
var L_Menu_LCID="1033";
var L_Menu_SiteTheme="";
//-->
</script>
<script type="text/javascript">
//<![CDATA[
var globalArg_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0;
var globalContext_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0;
function ExpGroupCallServerg_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0(arg, context)
{
    globalArg_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0 = "GroupString=" + arg + "&ConnectionFilterString=";
    globalContext_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0 = context;
    setTimeout("WebForm_DoCallback('ctl00$m$g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0',globalArg_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0,ExpGroupReceiveData,globalContext_g_8bd325df_1ef5_4c59_9cf9_133a68ebd1c0,ExpGroupOnError,true)", 0);
}
function ExpGroupOnError(message, context) {
alert('An error has occurred with the data fetch.  Please refresh the page and retry.');
}
if (typeof(_spBodyOnLoadFunctionNames) != "undefined") {
if (_spBodyOnLoadFunctionNames != null) {
_spBodyOnLoadFunctionNames.push("ExpGroupOnPageLoad");
}
}//]]>
</script>
<script src="../../WebResource.axd_d_T_sWwmChWv5_0o-vuzl71g2_t_633965588901821931.js" type="text/javascript"></script>
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEWBALA+bGbCAKh5+UkAq/TrIoDAqrQ2/8G5Y7wS/NRsI/oWLYV4ff/9Cutpgo="/>
<!-- begin MAIN LAYOUT -->
		<div id="DSM_MainContainer">
			<div id="DSM_Header">	
	<!---- begin ACCESSIBILITY FEATURE ---->
					<div id="TurnOnAccessibility" style="display:none">
			   		<a href="#" class="ms-skip" onclick="SetIsAccessibilityFeatureEnabled(true);UpdateAccessibilityUI();return false;">
					Turn on more accessible mode</a></div>
					<a href="javascript:;" onclick="javascript:this.href='#mainContent';" class="ms-skip" accesskey="J">
					Skip to main content</a>
			  		<div id="TurnOffAccessibility" style="display:none">
					<a href="#" class="ms-acclink" onclick="SetIsAccessibilityFeatureEnabled(false);UpdateAccessibilityUI();return false;">
					Turn off more accessible mode</a></div>
	<!---- end ACCESSIBILITY FEATURE ---->
	<!-- begin UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
	<div id="SP_adminBar">
		<tr><td colspan="4" id="mpdmconsole" class="ms-consolemptablerow">
<!-- Console -->
<span id="ctl00_SPNavigation_ctl01_publishingContext1"></span>
<!-- Console -->
</td></tr>
	</div>
<!-- end UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
				<h1><a href="/">American Psychiatric Association DSM-5 Development</a></h1>	
				<div id="DSM_UtilityLinks"><a href="http://www.psychiatry.org/">www.psychiatry.org</a></div>
				<!--<div id="DSM_UtilityLinks3"><a href="/pages/registration.aspx">Volunteer for Field Trials</a></div>-->
				<div id="DSM_UtilityLinks2"><a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use</a></div>
				<div id="DSM_SearchForm">
					<table>
						<tr>
							<td><input type="text" id="searchTerm" onkeydown="searchSubmitEnter()"/></td>
							<td><img src="../../Style Library/DSM_Images/search.gif" alt="Search" id="searchBtn" onclick="searchSubmitClick()"/></td>
						</tr>
					</table>					
				</div>			
			</div>	
			<div id="DSM_TopNavBar">
<!---- begin TOP NAVIGATION ---->		
			<table id="zz1_TopNavigationMenu" class="ms-topNavContainer zz1_TopNavigationMenu_2" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td onmouseover="Menu_HoverRoot(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun0"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4 DSM_staticNavSelected zz1_TopNavigationMenu_9" cellpadding="0" cellspacing="0" border="0" width="100%">
			<tr>
				<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3 DSM_staticNavSelected zz1_TopNavigationMenu_8" href="/" accesskey="1">Home</a></td>
			</tr>
		</table></td><td width="0"></td><td><table border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="About DSM-5" id="zz1_TopNavigationMenun1"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../about/Pages/Default.html">About DSM-5</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Meet Us" id="zz1_TopNavigationMenun2"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../MeetUs/Pages/Default.html">Meet Us</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Research Background" id="zz1_TopNavigationMenun3"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../Research/Pages/Default.html">Research Background</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="General Resources" id="zz1_TopNavigationMenun4"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../ProgressReports/Pages/Default.html">General Resources</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-5 Proposed Revisions" id="zz1_TopNavigationMenun5"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../proposedrevision/Pages/Default.html">Proposed Revisions</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Newsroom" id="zz1_TopNavigationMenun6"><table class="DSM_staticNavItem zz1_TopNavigationMenu_4" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="zz1_TopNavigationMenu_1 DSM_staticNavItem zz1_TopNavigationMenu_3" href="../../Newsroom/Pages/Default.html">Newsroom</a></td>
					</tr>
				</table></td><td width="0"></td>
			</tr>
		</table><div id="zz1_TopNavigationMenun1Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-V Overview" id="zz1_TopNavigationMenun7">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/DSMVOverview.html">DSM-5 Overview: The Future Manual</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Timeline" id="zz1_TopNavigationMenun8">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/Timeline.html">Timeline</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Board of Trustee Principles" id="zz1_TopNavigationMenun9">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Frequently Asked Questions" id="zz1_TopNavigationMenun10">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun1ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun1ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun2Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Task Force Members" id="zz1_TopNavigationMenun11">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../MeetUs/Pages/TaskForceMembers.html">Task Force Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Study Group Members" id="zz1_TopNavigationMenun12">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../MeetUs/Pages/StudyGroupMembers.html">Study Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Work Group Members" id="zz1_TopNavigationMenun13">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../MeetUs/Pages/WorkGroupMembers.html">Work Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun14">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun2ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun2ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun3Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun15">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Research/Pages/ConferenceSummariesandMonographs.html">DSM-5 Research Planning Conference Summaries and Monographs</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun16">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Research/Pages/Presentations.html">Presentations on DSM-5 and Related Topics</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun17">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Research/Pages/Publications.html">Publications from DSM-5 Development</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun18">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Research/Pages/DSM-5FieldTrials.html">DSM-5 Field Trials</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun3ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun3ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun5Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurodevelopmental Disorders" id="zz1_TopNavigationMenun19">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/NeurodevelopmentalDisorders.html">Neurodevelopmental Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Schizophrenia Spectrum and Other Psychotic Disorders" id="zz1_TopNavigationMenun20">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/SchizophreniaSpectrumandOtherPsychoticDisorders.html">Schizophrenia Spectrum and Other Psychotic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Bipolar and Related Disorders" id="zz1_TopNavigationMenun21">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/BipolarandRelatedDisorders.html">Bipolar and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Depressive Disorders" id="zz1_TopNavigationMenun22">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/DepressiveDisorders.html">Depressive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Anxiety Disorders" id="zz1_TopNavigationMenun23">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/AnxietyDisorders.html">Anxiety Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Obsessive-Compulsive and Related Disorders" id="zz1_TopNavigationMenun24">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/Obsessive-CompulsiveandRelatedDisorders.html">Obsessive-Compulsive and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Trauma and Stressor Related Disorders" id="zz1_TopNavigationMenun25">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/TraumaandStressorRelatedDisorders.html">Trauma- and Stressor-Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Dissociative Disorders" id="zz1_TopNavigationMenun26">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/DissociativeDisorders.html">Dissociative Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Somatic Symptom Disorders" id="zz1_TopNavigationMenun27">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/SomaticSymptomDisorders.html">Somatic Symptom Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Feeding and Eating Disorders" id="zz1_TopNavigationMenun28">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/FeedingandEatingDisorders.html">Feeding and Eating Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Elimination Disorders" id="zz1_TopNavigationMenun29">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/EliminationDisorders.html">Elimination Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sleep-Wake Disorders" id="zz1_TopNavigationMenun30">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/Sleep-WakeDisorders.html">Sleep-Wake Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sexual Dysfunctions" id="zz1_TopNavigationMenun31">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/SexualDysfunctions.html">Sexual Dysfunctions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Gender Dysphoria" id="zz1_TopNavigationMenun32">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/GenderDysphoria.html">Gender Dysphoria</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Disruptive, Impulse Control, and Conduct Disorders" id="zz1_TopNavigationMenun33">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/Disruptive_ImpulseControl_andConductDisorders.html">Disruptive, Impulse Control, and Conduct Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Substance Use and Addictive Disorders" id="zz1_TopNavigationMenun34">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/SubstanceUseandAddictiveDisorders.html">Substance Use and Addictive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurocognitive Disorders" id="zz1_TopNavigationMenun35">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/NeurocognitiveDisorders.html">Neurocognitive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Personality Disorders" id="zz1_TopNavigationMenun36">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/PersonalityDisorders.html">Personality Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Paraphilic Disorders" id="zz1_TopNavigationMenun37">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/ParaphilicDisorders.html">Paraphilic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Other Disorders" id="zz1_TopNavigationMenun38">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/OtherDisorders.html">Other Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed DSM-5 Organizational Structure and Disorder Names" id="zz1_TopNavigationMenun39">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/proposed-dsm5-organizational-structure-and-disorder-names.html">Proposed DSM-5 Organizational Structure and Disorder Names</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed Mental Disorder Definitions" id="zz1_TopNavigationMenun40">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/proposedrevision_rid_465.html">Proposed Mental Disorder Definitions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun41">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../proposedrevision/Pages/Cult.html">DSM-5 Cultural Formulation Interview</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun5ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun5ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun6Items" class="zz1_TopNavigationMenu_0 DSM_dynamicNav zz1_TopNavigationMenu_7">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun42">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Newsroom/Pages/PressReleases.html">Press Releases</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun43">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Newsroom/Pages/MediaContact.html">Media Contact</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="FAQ" id="zz1_TopNavigationMenun44">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun45">
					<td><table class="DSM_dynamicNavItem zz1_TopNavigationMenu_6" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="zz1_TopNavigationMenu_1 DSM_dynamicNavItem zz1_TopNavigationMenu_5" href="../../Newsroom/Pages/Commentaries.html">Commentaries, Responses, and Other DSM-5 News </a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun6ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem zz1_TopNavigationMenu_6 zz1_TopNavigationMenu_0" id="zz1_TopNavigationMenun6ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div></td>
	</tr>
</table>
<!---- end TOP NAVIGATION ---->
		</div>
			<div id="DSM_MainContent">
<!---- begin MAIN CONTENT AREA ---->
		<a name="mainContent"></a>
	<div id="DSM_LeftCol">	
		<div id="DSM_Breadcrumbs">
			<span id="ctl00_PlaceHolderMain_siteMapPath"><a href="#ctl00_PlaceHolderMain_siteMapPath_SkipLink"><img alt="Skip Navigation Links" height="0" width="0" src="../../WebResource.axd_d_nmHMzpcb8opA4_TBGiLLxg2_t_633965588901821931.jpg" border="0"/></a><span><a class="DSM_bcNode" href="/">Home</a></span><span class="DSM_bcSeparator"> / </span><span><a title="Proposed Revisions" class="DSM_bcNode" href="../../ProposedRevisions/Pages/Default.html">Proposed Revisions</a></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcCurrent">Proposed Revision</span><a id="ctl00_PlaceHolderMain_siteMapPath_SkipLink"></a></span>		
		</div>									
		<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ2" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="3f2d429f-e45d-4299-8ebf-e8597f5fcbab" haspers="false" id="WebPartWPQ2" width="100%" allowdelete="false" style=""><table border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr><td><table border="0" cellspacing="0" width="100%"><tr><td><h1><span><br>Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure </span></h1><div class="DSM_TabBar"><ul><li><a href="#" id="DSM_Tab_Proposed" class="DSM_TabOn" onclick="TabClick('Proposed','Rationale','Severity','DSM-IV')">Proposed   
								&nbsp;Revision</a></li><li><a href="#" id="DSM_Tab_Rationale" class="DSM_TabOff" onclick="TabClick('Rationale','Proposed','Severity','DSM-IV')">Rationale</a></li><li><a href="#" id="DSM_Tab_Severity" class="DSM_TabOff" onclick="TabClick('Severity','Proposed','Rationale','DSM-IV')">Severity</a></li><li><a href="#" id="DSM_Tab_DSM-IV" class="DSM_TabOff" onclick="TabClick('DSM-IV','Proposed','Rationale','Severity')">DSM-IV</a></li></ul><div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="0" height="0" alt=""></div></div><div id="DSM_TabContent_Proposed"><span style="font-family:'arial','sans-serif';font-size:10pt"><span style="font-family:'arial','sans-serif';font-size:10pt">
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure </span></b><span style="font-family:'times new roman','serif';font-size:12pt"></span></p>
<p style="text-align:right;line-height:normal;margin-bottom:6pt" class="MsoNormal" align="right"><i><span style="font-family:'arial','sans-serif';font-size:10pt">Update May 1, 2012</span></i></p>
<p style="text-align:right;line-height:normal;margin-bottom:6pt" class="MsoNormal" align="right"><i><span style="font-family:'arial','sans-serif';font-size:10pt"></span></i><span style="font-family:'times new roman','serif';font-size:12pt"></span> </p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">This condition is being recommended for further study in Section III, which is the section of the DSM-5 text in which conditions that require further research will be included.</span><span style="font-family:'times new roman','serif';font-size:12pt"></span></p></span>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpFirst" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt"><span></span></span> </p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpFirst" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>A.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">More than minimal exposure to alcohol at any time during gestation, including prior to pregnancy recognition</span><span style="font-family:'arial','sans-serif';font-size:10pt">. Confirmation of gestational exposure to alcohol may be obtained from any of the following sources: maternal self-report of alcohol use in pregnancy</span><span style="font-family:'arial','sans-serif';font-size:10pt">, collateral reports, or medical or other records</span><span style="font-family:'arial','sans-serif';font-size:10pt">.</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>B.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Neurocognitive impairment, as evidenced by one (or more) of the following:</span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>1.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">global intellectual impairment (</span><span style="font-family:'arial','sans-serif';font-size:10pt">i.e.,</span><span style="font-family:'arial','sans-serif';font-size:10pt"> IQ of 70 or below, or a standard score of 70 or below on a comprehensive developmental assessment</span><span style="font-family:'arial','sans-serif';font-size:10pt">)</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>2.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment in e</span><span style="font-family:'arial','sans-serif';font-size:10pt">xecutive functioning (</span><span style="font-family:'arial','sans-serif';font-size:10pt">e.g., </span><span style="font-family:'arial','sans-serif';font-size:10pt">poor planning and organization; difficulty changing strategies or inflexibility; difficulty with behavioral inhibition)</span></p>
<p style="margin-left:0.75in" class="MsoListParagraphCxSpMiddle"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>3.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment in learning</span><span style="font-family:'arial','sans-serif';font-size:10pt"> </span><span style="font-family:'arial','sans-serif';font-size:10pt">(</span><span style="font-family:'arial','sans-serif';font-size:10pt">e.g., </span><span style="font-family:'arial','sans-serif';font-size:10pt">lower academic achievement than expected for intellectual level; requires special education services; specific learning disability)</span></p>
<p style="margin-left:0.75in" class="MsoListParagraphCxSpMiddle"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>4.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment in memory</span><span style="font-family:'arial','sans-serif';font-size:10pt"> </span><span style="font-family:'arial','sans-serif';font-size:10pt">(</span><span style="font-family:'arial','sans-serif';font-size:10pt">e.g., </span><span style="font-family:'arial','sans-serif';font-size:10pt">problems remembering information learned recently; repeatedly making the same mistakes; difficulty remembering lengthy verbal instructions)</span></p>
<p style="margin-left:0.75in" class="MsoListParagraphCxSpMiddle"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>5.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment in v</span><span style="font-family:'arial','sans-serif';font-size:10pt">isual spatial reasoning (e.g., disorganized or poorly planned drawings or constructions; problems differentiating left from right; problems aligning numbers in columns)</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>C.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Impairment in self-regulation in one (or more) of the following: </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>1.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment in m</span><span style="font-family:'arial','sans-serif';font-size:10pt">ood or behavioral regulation (</span><span style="font-family:'arial','sans-serif';font-size:10pt">e.g., </span><span style="font-family:'arial','sans-serif';font-size:10pt">mood lability; negative affect or irritability; frequent behavioral outbursts)</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>2.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">attention </span><span style="font-family:'arial','sans-serif';font-size:10pt">deficit </span><span style="font-family:'arial','sans-serif';font-size:10pt">(</span><span style="font-family:'arial','sans-serif';font-size:10pt">e.g., </span><span style="font-family:'arial','sans-serif';font-size:10pt">difficulty encoding new information; difficulty shifting attention; difficulty sustaining mental effort)</span></p>
<p style="margin-left:0.75in" class="MsoListParagraphCxSpMiddle"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>3.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment in i</span><span style="font-family:'arial','sans-serif';font-size:10pt">mpulse control (e.g., difficulty waiting turn; difficulty complying with rules; confabulating; taking possessions of others)</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>D.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Deficits in adaptive functioning as manifested in two (or more) of the following, including at least one of (1) or (2):</span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>1.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">communication </span><span style="font-family:'arial','sans-serif';font-size:10pt">deficit </span><span style="font-family:'arial','sans-serif';font-size:10pt">(</span><span style="font-family:'arial','sans-serif';font-size:10pt">e.g., </span><span style="font-family:'arial','sans-serif';font-size:10pt">delayed acquisition of language; difficulty understanding spoken language; difficulty using language to express self so that the listener understands)</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>2.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">social </span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment </span><span style="font-family:'arial','sans-serif';font-size:10pt">(</span><span style="font-family:'arial','sans-serif';font-size:10pt">e.g., </span><span style="font-family:'arial','sans-serif';font-size:10pt">overly friendly with strangers; difficulty reading social cues; difficulty understanding social consequences; acting “too young”)</span></p>
<p style="margin-left:0.75in" class="MsoListParagraphCxSpMiddle"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>3.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment in d</span><span style="font-family:'arial','sans-serif';font-size:10pt">aily living (e.g., delayed toileting, feeding, or bathing; problems following rules of personal safety; difficulty managing daily schedule)</span></p>
<p style="margin-left:0.75in" class="MsoListParagraphCxSpMiddle"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.75in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>4.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">motor </span><span style="font-family:'arial','sans-serif';font-size:10pt">impairment </span><span style="font-family:'arial','sans-serif';font-size:10pt">(</span><span style="font-family:'arial','sans-serif';font-size:10pt">e.g., poor fine motor development; </span><span style="font-family:'arial','sans-serif';font-size:10pt">delayed attainment of gross motor milestones or ongoing deficits in gross motor function; problems in coordination and balance)</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>E.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">The onset of the disturbance (symptoms in Criteria B, C, and D) is before 18 years of age.</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>F.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. </span></p>
<p class="MsoListParagraphCxSpMiddle"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpLast"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>G.<span style="font:7pt 'times new roman'">    </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">The disturbance is not better explained by the direct physiological effects associated with postnatal use of a substance (e.g., medication, alcohol or other drugs), another medical condition (e.g., traumatic brain injury, delirium, dementia), other known teratogens (e.g., Fetal Hydantoin syndrome), a genetic condition (e.g., Williams syndrome, Down syndrome, Cornelia de Lange syndrome), or environmental neglect.</span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpLast"></span></p><font size="2" face="Arial"></font></div><div id="DSM_TabContent_Rationale"><p align="center"><strong><font size="2" face="Arial">Rationale for the Inclusion of <span>Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure in Section III of the DSM-5</span>  </font></strong></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span> </p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">1.<span>  </span><u>A Need for the Category </u></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Alcohol is a neurobehavioral teratogen, and a large body of experimental animal research, longitudinal human studies and clinical research all document the teratogenic effects of prenatal alcohol exposure (PAE) on fetal growth and development and on central nervous system function and behavior throughout the lifespan.<span>  </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">This extensive research has shown that PAE results in a set of diagnostic conditions that fall on a spectrum, a point that was also made in the original definition of alcohol-related conditions by the Institute of Medicine </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(</span><a title="Stratton, 1996 #1" href="#_enref_236"><span style="color:windowtext;text-decoration:none;text-underline:none">Stratton, Howe, & Battaglia, 1996</span></a><span>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. <span> </span>Accordingly, these have collectively been labeled as Fetal Alcohol Spectrum Disorders (FASD or FASDs).<span>  </span>The term “fetal alcohol spectrum disorders” was accepted in 2004 by consensus of governmental, research and advocacy organizations (<a href="http://www.nofas.org/advocate/terminology.aspx">http://www.nofas.org/advocate/terminology.aspx</a> ) and is considered a global public health concern.<span>  </span>FASD, as an umbrella term, includes the more specific diagnostic conditions of what the Institute of Medicine previously termed Fetal Alcohol Syndrome (FAS), partial FAS, Alcohol Related Neurodevelopmental Disorder (ARND), and Alcohol Related Birth Defects (ARBD).<span>  </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Although the IOM’s diagnostic coding schema has been useful in delineating the variation in the physical characteristics associated with PAE, it does not adequately provide a method of describing the neurodevelopmental and mental health symptoms associated with PAE. As a result, the service needs of many children with PAE are not identified or are often inappropriately treated by mental health professionals. The term <i>Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure (ND-PAE) </i>is a new clarifying term, intended to encompass the full range of developmental disabilities associated with exposure to alcohol in utero. The current diagnostic guidelines allow ND-PAE to be diagnosed both in the presence or absence of the physical effects of PAE. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Individuals diagnosed with ND-PAE have brain damage that can result in a variety of neurodevelopmental outcomes with individual variation in their presentation. This is consistent with extensive data on the mechanisms of alcohol as a neurobehavioral teratogen </span><span><span>(</span><a title="Goodlett, 2005 #4" href="#_enref_78"><span style="color:windowtext;text-decoration:none;text-underline:none">Goodlett, Horn, & Zhou, 2005</span></a><span>; </span><a title="Guerri, 2009 #5" href="#_enref_82"><span style="color:windowtext;text-decoration:none;text-underline:none">Guerri, Bazinet, & Riley, 2009</span></a><span>; </span><a title="Guerri, 2001 #6" href="#_enref_83"><span style="color:windowtext;text-decoration:none;text-underline:none">Guerri, Pascual, & Renau-Piqueras, 2001</span></a><span>; </span><a title="Weinberg, 2008 #7" href="#_enref_259"><span style="color:windowtext;text-decoration:none;text-underline:none">Weinberg, Sliwowska, Lan, & Hellemans, 2008</span></a><span>)</span>. There are several comprehensive literature reviews on these outcomes </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(</span><a title="Kable, 2004 #9" href="#_enref_104"><span style="color:windowtext;text-decoration:none;text-underline:none">Kable & Coles, 2004b</span></a><span>; </span><a title="Kodituwakku, 2009 #8" href="#_enref_113"><span style="color:windowtext;text-decoration:none;text-underline:none">Kodituwakku, 2009a</span></a><span>; </span><a title="Mattson, 2010 #11" href="#_enref_148"><span style="color:windowtext;text-decoration:none;text-underline:none">Mattson, Vaurio, et al., 2010</span></a><span>; </span><a title="Riley, 2005 #10" href="#_enref_205"><span style="color:windowtext;text-decoration:none;text-underline:none">Riley & McGee, 2005</span></a><span>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The omission from the DSM of a diagnosis describing this constellation of impairments has likely contributed to the difficulty many of these individuals and their families experience in accessing appropriate services for mental health issues.<span>  </span>Of particular concern, individuals impacted by PAE are significantly over-represented yet under-recognized in the child welfare system, juvenile detention and correctional facilities, and inpatient psychiatric settings.<span>  </span>Many of these individuals are seen in outpatient mental health settings, but are often not appropriately identified.<span>  </span>Consequently, these individuals are frequently treated inappropriately (often to their considerable detriment) by mental health, educational, and criminal justice systems.<span>  </span>Previous research on outcomes for individuals with<span>  </span>a history of PAE, but who did not meet full criteria for FAS, has found them to be at higher risk for a number of adverse life outcomes, including delinquency, school failure, and alcohol and drug abuse problems than individuals who did meet full criteria for FAS.<span>  </span>Such findings may seem surprising, but this pattern may occur in part because these individuals are less readily identified as needing services, and are less likely to qualify for and receive services than the much smaller group of individuals who meet full criteria for FAS.<span>  </span>The inclusion of a diagnosis of ND-PAE in the DSM-5 would undoubtedly facilitate recognition of individuals negatively impacted by PAE who may be in need of treatment, regardless of whether or not they demonstrate the associated physical sequelae of dysmorphic facial features and growth impairment.<span>   </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">2.<span>  </span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span> </span><u>Relationship with Other DSM-5 Diagnoses</u></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Children with ND-PAE have been found to have a higher incidence of oppositional defiant (ODD) and conduct disorder (CD) symptoms </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Disney, 2008 #207" href="#_enref_63"><span style="color:windowtext;text-decoration:none;text-underline:none">Disney, Iacono, McGue, Tully, & Legrand, 2008</span></a>; <a title="Walthall, 2008 #206" href="#_enref_260"><span style="color:windowtext;text-decoration:none;text-underline:none">Walthall, O'Connor, & Paley, 2008</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. Clinicians making a dual diagnosis of ND-PAE and ODD or CD should make sure that the symptoms associated with ODD and CD are not primarily a reflection of the brain damage or lower cognitive functioning seen in ND-PAE. For example, poor comprehension of requests or commands may sometimes appear to be noncompliant behavior, confabulation may be mistaken for lying, and poor understanding of ownership may result in a child taking things that do not belong to them. Symptoms of depression and mania </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Famy, 1998 #211" href="#_enref_68"><span style="color:windowtext;text-decoration:none;text-underline:none">Famy, Streissguth, & Unis, 1998</span></a>; <a title="Fryer, 2007 #209" href="#_enref_73"><span style="color:windowtext;text-decoration:none;text-underline:none">Fryer, McGee, Matt, Riley, & Mattson, 2007</span></a>; <a title="O'Connor, 2000 #208" href="#_enref_173"><span style="color:windowtext;text-decoration:none;text-underline:none">O'Connor & Kasari, 2000</span></a>; <a title="O'Connor, 2002 #210" href="#_enref_174"><span style="color:windowtext;text-decoration:none;text-underline:none">O'Connor, Kogan, & Findlay, 2002</span></a>; <a title="Walthall, 2008 #206" href="#_enref_260"><span style="color:windowtext;text-decoration:none;text-underline:none">Walthall, et al., 2008</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> have been reported as well as an increased incidence of somatoform disorder, substance dependence or abuse disorders, and paranoid, passive-aggressive, and antisocial personality disorders in adults with PAE (Barr et al., 2006;<span> <a title="Yates, 1998 #213" href="#_enref_273"><span style="color:windowtext;text-decoration:none;text-underline:none">Yates, Cadoret, Troughton, Stewart, & Giunta, 1998</span></a>)</span> but the most common mental health diagnosis given to individuals with ND-PAE is ADHD (Peadon & Elliott, 2010). Table 1 contains fourteen published studies comparing children with a history of PAE to those with ADHD. Although initially similarities were identified between the two disorders (Nanson and Hiscock, 1990), examination of the two disorders over the years has resulted in the conclusion that ND-PAE and ADHD have distinctive neuropsychological characteristics with some symptom overlap. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">In a careful review of the literature comparing children with PAE and children with ADHD, Mattson and her colleagues (Mattson, Crocker, & Nguyen, 2011) concluded that children with PAE had more difficulty with problem-solving, verbal fluency, overall IQ, shifting attention, verbal encoding, daily living skills, and face and emotion processing than do children with ADHD. In contrast, children with ADHD have more difficulties with basic motor control, focused attention, sustained attention, and retrieval than do children with PAE. <span> </span>Symptom overlap between the disorders was identified in the areas of set shifting, complex motor skills, static balance, social skills, communication skills, and parental report of behavioral problems. In addition, children with PAE may differ from children with ADHD in key aspects of executive functioning involved in modulating relationships between attention and arousal level. <span> </span>Using a sustained attention task, children with PAE were found to have more difficulties with conditions associated with over-arousal; whereas, individuals with ADHD demonstrated deficits in the under-arousal condition </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Kooistra, 2010 #164" href="#_enref_119"><span style="color:windowtext;text-decoration:none;text-underline:none">Kooistra, et al., 2010</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. Individuals with ADHD were also found to differ from those with PAE in the pattern of their neural processing using event-related potentials as outcome measures while engaged in an inhibition task </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Burden, 2010 #163" href="#_enref_26"><span style="color:windowtext;text-decoration:none;text-underline:none">Burden, et al., 2010</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Studies assessing the response of children with PAE to standard pharmacological treatments commonly used to treat children with ADHD have produced mixed results. Table 2 contains human and animal model studies assessing the impact of pharmacological Interventions on attention and activity level. A fixed dose crossover study of four children with ND-PAE, </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Oesterheld, 1998 #165" href="#_enref_183"><span style="color:windowtext;text-decoration:none;text-underline:none">Oesterheld, et al., 1998</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> found positive effects of methylphenidate compared to placebo on parent and teacher ratings of hyperactive and impulsive symptoms, but no such effects for objective measures of inattention.<span>  </span>In another crossover study of 11 children with PAE and ADHD, Snyder, Nanson, Snyder, and Block </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Snyder, 1997 #166" href="#_enref_225"><span style="color:windowtext;text-decoration:none;text-underline:none">1997</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> found significant effects for stimulants compared to placebo on parent reports of hyperactive symptoms, but no improvement in measures of attention or impulsivity.<span>  </span>Retrospective studies of medication response among individuals with PAE have also yielded mixed results.<span>  </span>O’Malley, Koplin, and Dohner<b> </b></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="O'Malley, 2000 #167" href="#_enref_179"><span style="color:windowtext;text-decoration:none;text-underline:none">2000</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> reported that in a sample of children diagnosed with FAS/ARND and ADHD, 79% of patients given dextroamphetamine showed a positive clinical response, whereas only 22% of the patients who were given methylphenidate showed a positive clinical response.<span>  </span>In a retrospective chart review of 22 patients with FASDs, Coe and colleagues </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Coe, 2001 #200" href="#_enref_40"><span style="color:windowtext;text-decoration:none;text-underline:none">2001</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> found 63% exhibited positive effects of stimulant medications on symptoms of impulsivity, inattentiveness, or hyperactivity but approximately one third of the trials had to be stopped due to concerns regarding negative side effects.<span>  </span>Most recently, Doig and colleagues </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Doig, 2008 #201" href="#_enref_64"><span style="color:windowtext;text-decoration:none;text-underline:none">2008</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> reviewed 41 medication trials in a sample of 27 children with PAE and ADHD.<span>  </span>The majority of the trials consisted of stimulant medications, although some included combinations of psychostimulants with other medications, such as clonidine, risperidone, or carbamazepine. Significant effects were seen on all three domains in the hyperactive/impulsive and oppositional/defiant but to a lesser extent in the inattentive domain.<span>  </span>Collectively, these suggest that inattentive symptoms are not effectively ameliorated by psychostimulant medications in children with FASD. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal models of PAE suggested reactivity to methylphenidate in the postnatal period is altered </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(<a title="Means, 1984 #204" href="#_enref_161"><span style="color:windowtext;text-decoration:none;text-underline:none">Means, Medlin, Hughes, & Gray, 1984</span></a>; <a title="Shen, 2006 #203" href="#_enref_220"><span style="color:windowtext;text-decoration:none;text-underline:none">Shen & Choong, 2006</span></a>; <a title="Ulug, 1983 #205" href="#_enref_257"><span style="color:windowtext;text-decoration:none;text-underline:none">Ulug & Riley, 1983</span></a>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">, resulting in increased activity and decreased excitability of the dopamine neurons in the ventral tegmental area (Shen & Choong, 2006). <span> </span>In contrast, reduced activity and improved performance on learning tasks have been found in response to choline supplementation delivered prenatally (Thomas et al., 2004) or postnatally (Thomas et al., 2007). The use of fenofibrate, which is lipid regulating agent that affects the nuclear receptors (i.e. peroxisome proliferator-actived receptor-PPAR-alpha), has also been found to minimize symptoms of hyperactivity after PAE but the impact of these substances with humans with ND-PAE is not yet known.</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Finally, the differential diagnosis of ND-PAE includes cognitive impairment or intellectual disability in the absence of PAE and several genetic and teratogenic conditions that share some common features with the disorder. Genetic conditions such as Cornelia de Lange Syndrome, Down Syndrome, and Dubowitz Syndrome and other teratogenic conditions such as Fetal Hydantoin Syndrome and Maternal Phenylketonuria may have similar physical characteristics to those seen in some children with PAE.<span>  </span>A careful review of prenatal exposure history is needed to clarify the teratogenic agent and an evaluation by a geneticist trained in dysmorphology may be needed to distinguish physical characteristics associated with these conditions from those commonly seen in children with ND-PAE.<span>  </span>Other considerations may include the direct physiological effects of use or misuse of a substance such as medication, alcohol or other drugs, or problems attributed to a general medical condition such as traumatic brain injury or other neurocognitive disorders (i.e. delirium, dementia). A careful history of the onset of the symptoms and current substance use should aid in differentiating these conditions from ND-PAE. </span></p>
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><br style="page-break-before:always" clear="all"></span>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Table 1 – </span><span class="apple-style-span"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Differences between the Neuropsychological Characteristics of Individuals with PAE and those with ADHD</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<table style="border-bottom:medium none;border-left:medium none;width:6.7in;border-collapse:collapse;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="804">
<tbody>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p style="text-align:center" class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">References</span></b></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="text-align:center;margin-left:0.5in" class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Sample</span></b></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="text-align:center;margin-left:0.05in" class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Results</span></b></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="text-align:center;margin-left:8.1pt" class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Conclusion</span></b></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Nanson & Hiscock, 1990</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">24 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">36 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.45in;margin-bottom:0pt;tab-stops:list 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">20 ADHD</span></p>
<p style="line-height:normal;text-indent:-0.45in;margin-bottom:0pt;tab-stops:list 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">20 PAE</span></p>
<p style="line-height:normal;text-indent:-0.45in;margin-bottom:0pt;tab-stops:list 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">20 Comparison sample</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Although Ss with PAE were significantly more impaired intellectually, their attentional deficits and behavioral problems were similar to those of ADHD Ss but PAE children were unable to make speed accuracy trade-offs in favor of speed found in the ADHD Ss</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Children with PAE have similar behavioral functioning as rated by parents and performance on sustained attention tasks as children with ADHD. The authors conclude that treatments known to facilitate learning in children with ADD may also benefit children with PAE</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Coles et al., 1997</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">72 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">77 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span> </span></span></p>
<p style="line-height:normal;text-indent:-12.6pt;margin:0in 0in 0pt 12.6pt;tab-stops:12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif'">27 ADHD</span></p>
<p style="line-height:normal;margin:0in 0in 0pt 12.6pt;tab-stops:12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:'arial','sans-serif'"> </span></p>
<p style="line-height:normal;text-indent:-12.6pt;margin:0in 0in 0pt 12.6pt;tab-stops:12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif'"><span> </span>PAE</span></p>
<p style="margin:0in 0in 0pt;tab-stops:12.6pt" class="ColorfulList-Accent11"><span style="font-family:'arial','sans-serif'"><span>       </span>25 Dysmorphic</span></p>
<p style="margin-left:12.6pt;tab-stops:12.6pt" class="ColorfulList-Accent11"><span style="font-family:'arial','sans-serif'"><span> </span>62 Nondysmorphic</span></p>
<p style="text-indent:-12.6pt;margin-left:12.6pt;tab-stops:12.6pt" class="ColorfulList-Accent11"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif'">35<span>  </span>Comparison<span>              </span><span> </span><span>  </span>sample</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE<span>  </span>Ss &gt; difficulty encoding information and performing on a shift task than ADHD Ss. </span></p>
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">ADHD Ss &gt; PAE <span> </span>Ss impairment in sustained attention</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Double dissociation was found in this study between the groups. PAE Ss had &gt; difficulty encoding information and flexible problem-solving than ADHD Ss. ADHD Ss had more difficulties with sustained attention. </span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Coffin, 2005</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">34 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">19 males </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">16 ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">10 PAE</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">14 Dyslexia</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">13<span>  </span>Comparison sample</span></p>
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE Ss & Dyslexia Ss had longer latencies and poorly timed responses to the condition stimulus than ADHD Ss.<span>  </span>ADHD Ss were impaired on measures of adaptively timed responses but conditioned responses were comparable to normal Ss.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Children with PAE demonstrated distinctly different pattern of eye-blink conditioning than did the ADHD children but were similar to those in the dyslexia group.</span></p></td></tr></tbody></table><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><br style="page-break-before:always" clear="all"></span>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<table style="border-bottom:medium none;border-left:medium none;width:6.7in;border-collapse:collapse;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="804">
<tbody>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Nash, 2006</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Gender distribution not reported</span></p>
<p style="line-height:normal;text-indent:-12.6pt;margin:0in 0in 0pt 12.6pt;tab-stops:list 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif'">30 PAE</span></p>
<p style="line-height:normal;text-indent:-12.6pt;margin:0in 0in 0pt 12.6pt;tab-stops:list 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif'">30 ADHD</span></p>
<p style="line-height:normal;text-indent:-12.6pt;margin:0in 0in 0pt 12.6pt;tab-stops:list 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif'">30 Comparison sample</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin:0in 0in 3pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE and ADHD were differentiated by two combinations of items from a behavioral questionnaire: (1) no guilt, cruelty, and acts young (sensitivity=70% & specificity=80%)</span></p>
<p style="margin:0in 0in 3pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">(2) acts young, cruelty, no guilt, lying or cheating, steals from home and outside. (sensitivity=81% & specificity=72%)</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Specific behavioral characteristics (see item lists) can differentiate PAE from ADHD. </span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Vaurio et al., 2008</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">23 females<span>  </span>and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">37 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">20 PAE</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">20 ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">20 Comparison sample</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin:0in 0in 3pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Deficits seen in both clinical groups on WCST performance and a relative weakness on letter vs. category fluency. The PAE group displayed relative weakness on Trail Making Test B vs. A</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Although executive function deficits occurred in both groups, the degree and pattern of deficit differed between the PAE and ADHD.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Herman, Acosta, & Chang, 2008</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">17 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">19 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.3in;margin:0in 0in 0pt 0.3in;tab-stops:list 12.6pt" class="ColorfulList-Accent11"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif'">36 PAE</span></p>
<p style="text-indent:-0.6in;margin:0in 0in 0pt 0.6in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>      </span>18 ADHD</span></p>
<p style="text-indent:-0.6in;margin:0in 0in 0pt 0.6in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>      </span>18 no ADHD</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE male Ss with ADHD performed better than PAE males without ADHD on TOVA omission scores. Among PAE girls, the pattern was the opposite. A similar pattern was seen for girls with PAE on the WISC-III but the boys did not differ.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin:0in 0in 3pt 7.9pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The conclusions from this study are complicated by the small sample size when analyzing 36 participants into equal ADHD/non ADHD groups and then looking for gender interactions within the group. The method of determining diagnoses of ADHD is also not reported. The authors conclude that among individuals with PAE having ADHD for females resulted in additional deficits in EF and for males was associated with better EF. </span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Crocker, 2009</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">27 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">38 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">22 PAE</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">23 ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">20 Comparison sample</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">ADHD and PAE Ss showed adaptive deficits in all domains relative to controls. PAE Ss were more impaired on daily living skills and PAE Ss demonstrated poorer communication and socialization scores at older ages</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin:0in 0in 3pt 7.9pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The pattern of impairment in adaptive functioning differed between PAE and ADHD Ss. Children with PAE<span>  </span>exhibited a lack of improvement with age in socialization and communication skills relative to peers, suggesting arrested development. The ADHD Ss demonstrated a stable delay across ages relative to controls.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Greenbaum et al, 2009</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">39 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">58 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">33 PAE</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">30 ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">34 Comparison sample</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE Ss demonstrated weaker social cognition and facial emotional processing than ADHD Ss.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Performance on tasks assessing social cognition and emotional processing resulted in a distinct behavioral profile between groups with PAE Ss having weaker social cognition and facial emotion processing skills.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Kooistra et al., 2009</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">48 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">68 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">30 PAE</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">47-ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">39 Comparison sample</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">ADHD and PAE Ss had more motor deficits than control Ss.</span></p>
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">More severe impairment was identified in ADHD Ss in perceptuo-motor functioning. ADHD Ss had early onset latencies of the tibialis anterior muscle and increased amplitudes<span>  </span>of the gastrocnemius muscle</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The key motor problem in ADHD Ss may be the difficulty with scaling muscle force, which reflects medial cerebellar involvement but the cerebellar involvement in the postural instability seen in PAE Ss was inconclusive.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Kooistra et al., 2010</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">48 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">68 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">30 PAE</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">47-ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">39 Comparison sample</span></p>
<p style="line-height:normal;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:'arial','sans-serif'"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">ADHD and PAE<span>  </span>Ss &gt; impairments on sustained attention over time. ADHD Ss &gt; impairment in slow Go/No-go<span>  </span>and PAE Ss &gt; impairment in fast Go/No-go</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Double dissociation between ADHD and PAE Ss suggesting ADHD Ss impaired in handling understimulation and PAE Ss impaired in handing overstimulation</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Burden et al., 2010</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">30 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">48 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">15- ADHD-no alcohol exposure</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">16-Alcohol exposure-no ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">15-Alcohol exposure and ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">32-Comparison sample</span></p>
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Participants with ADHD, regardless of PAE history, were less accurate at inhibiting responses. ADHD with no PAE<span>  </span>&lt;<span>  </span>P3 difference between No-go and Go</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">ADHD symptoms seen in Ss with PAE were associated with different neurophysiologic responses (P3) than those with ADHD symptoms that did not have a history of PAE. </span></p>
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Individuals with PAE have a unique endophenotype, which may require different treatment approaches.</span></p></td></tr></tbody></table><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><br style="page-break-before:always" clear="all"></span>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<table style="border-bottom:medium none;border-left:medium none;width:6.7in;border-collapse:collapse;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="804">
<tbody>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Crocker et al., 2011</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">30 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">36 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpFirst"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">22-PAE</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt;tab-stops:12.6pt" class="ColorfulList-Accent11CxSpMiddle"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">22-ADHD<span>      </span></span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11CxSpLast"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">22-Comparison sample</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">All groups differed on learning trials (CON &gt; ADHD &gt; PAE); On delayed trials, CON &gt; ADHD, PAE. </span></p>
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">ADHD &lt; CON on retention but PAE did not differ</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Different patterns of deficit seen on a verbal learning task. PAE associated with inefficient encoding and ADHD associated with deficits in retrieval.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="144">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Jacobson et al, 2011</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:99pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="165">
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">111 females and </span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">151 males</span></p>
<p style="margin:0in 0in 0pt 0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">216-PAE</span></p>
<p style="text-indent:-9.35pt;margin:0in 0in 3pt 30.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">81 ADHD</span></p>
<p style="text-indent:-9.35pt;margin:0in 0in 3pt 30.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">135 Non-ADHD</span></p>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 0pt 12.6pt;tab-stops:12.6pt" class="ColorfulList-Accent11"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif'">46-Non-exposed<span>        </span></span></p>
<p style="text-indent:-9.35pt;margin:0in 0in 3pt 30.95pt;tab-stops:62.25pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">5 ADHD</span></p>
<p style="text-indent:-9.35pt;margin:0in 0in 3pt 30.95pt;tab-stops:62.25pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">41 Non-ADHD</span></p>
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="233">
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Heavily exposed 4 times more likely to meet criteria for ADHD than non-exposed offspring of mothers who were abstainers. Relative to number processing,</span></p>
<p style="margin-left:0.05in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE was associated with deficits in magnitude comparison while ADHD was not.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:157.5pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="263">
<p style="margin-left:8.1pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Arithmetic difficulties in ADHD Ss are mediated by domain-general deficits in overall cognitive ability and PAE Ss’ arithmetic difficulties are associated with specific deficits in the ability to mentally represent and manipulate a number. Math interventions should be different for the two groups to appropriately remediate given the origins of the problem.</span></p></td></tr></tbody></table>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">References above are linked to reference list of white paper.</span></p><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><br style="page-break-before:always" clear="all"></span>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Table 2 – Comparison of Response to Pharmacological Interventions after PAE</span></p>
<table style="border-bottom:medium none;border-left:medium none;width:640px;border-collapse:collapse;height:580px;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="640">
<tbody>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p style="text-align:center" class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">References</span></b></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p style="text-align:center;margin-left:0.05in" class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Sample</span></b></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p style="text-align:center;margin-left:6pt" class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Results</span></b></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="text-align:center;margin-left:7.95pt" class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Conclusion</span></b></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Snyder et al. 1997</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">11 PAE</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Improvements in response to various ADHD medications (Methylphenidate (MPH) MPH-SR, Pemoline, or Dexedrine) vs placebo in the areas of hyperactive symptoms per non-blinded parental report but no improvement in attention or impulsivity on a computerized attention task.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Typical ADHD medications<span>  </span>improved hyperactive symptoms but not attention or impulsivity symptoms in children with PAE.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Oesterheld et al., 1998</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">4 PAE</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Double blind study. Positive effects of MPH vs placebo on parent and teacher ratings of hyperactivity and impulsivity but not parent ratings of inattentiveness.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">MPH improved hyperactivity and impulsivity symptoms but not inattentive symptoms in children with PAE.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">O’Malley et al., 2000</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">8 female and </span></p>
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">22 male</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">30 PAE</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Archival clinical record review: 79% positive response to dextroamphetamine compared to 22% on methylphenidate (MPH).</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE symptoms were less responsive to MPH than dextroamphetamine. This may reflect differential action on the mesolimbic dopaminergic system in PAE.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Coe et al, 2001</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p style="text-indent:-12.6pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">22 PAE with 66 medication trials</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Archival clinical record review: 63% positive response to stimulants; 88% to mood stabilizers; 83% antipsychotics.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Authors recommend aggressive medication treatment to ameliorate secondary disabilities seen in these patients. Mood stabilizers and antipsychotics were more effective than stimulants.</span></p></td></tr></tbody></table><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><br style="page-break-before:always" clear="all"></span>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<table style="border-bottom:medium none;border-left:medium none;width:644px;border-collapse:collapse;height:638px;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="644">
<tbody>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Doig et al. 2008</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">8 females and </span></p>
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">19 males</span></p>
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-12.6pt;margin:0in 0in 0pt 12.6pt" class="ColorfulList-Accent11"><span style="font-family:symbol"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif'">27 PAE with 41 medication trials</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Archival clinical record review: Used the Texas Children’s Medication Algorithm to determine medication choices. 10 Ss in 1 trial, 10 in 2 trials, & 1 in 5 trials. 17 of 19 in methylphenidate trials received best scores for inattention while taking it, 14 on hyperactivity, and 15 on oppositional defiance. 7 of 12 received best scores for inattention on an amphetamine-based product. 6 had best scores on hyperactivity/impulsivity and 5 on oppositional defiance. Changes scores significant for all.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE children were found to benefit from methylphenidate and amphetamine-based pharmacological interventions. No control or comparison groups were used and medication trials were not blinded.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Frankel et al, 2006</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">37 females & </span></p>
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">40 males</span></p>
<p style="margin-bottom:0pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="text-indent:-12.6pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">28-Stimulant</span></p>
<p style="text-indent:-12.6pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">13-Neuroleptic</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Randomized to social skills group but medication assignment was based on clinical decision-archival record review. Children prescribed neuroleptics demonstrated greater improvement on all outcomes when compared to those who did not receive medication as compared to those prescribed stimulants who showed no improvement or poorer outcomes.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Neuroleptics were more beneficial in facilitating learning in response to a social skills intervention than were psychostimulants.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:6.7in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="804" colspan="4">
<p style="text-align:center;margin:0in 0in 5pt 7.9pt" class="MsoNormal" align="center"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="text-align:center;margin:0in 0in 5pt 7.9pt" class="MsoNormal" align="center"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal Model Studies</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Ulug & Riley, 1983</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal model of PAE</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">0-MPH dose</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">2 mg/kg MPH</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">8.6 mg/kg MPH</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">MPH did not reduce the overactivity of the PAE animals.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE increased reactivity to the stimulating effects of methylphenidate, making PAE animals more active rather than less.</span></p></td></tr></tbody></table><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><br style="page-break-before:always" clear="all"></span>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<table style="border-bottom:medium none;border-left:medium none;width:647px;border-collapse:collapse;height:667px;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="647">
<tbody>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Means et al, 1984</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal model of PAE</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">0-MPH dose</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">1 mg/kg MPH</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">2 mg/kg MPH</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">4 mg/kg MPH</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">MPH increased the frequency of<span>   </span>ambulation. MPH produced &gt; increases in area and duration of ambulation among PAE animals. Linear dose-response relationship of MPH in PAE.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">PAE alters animal reactivity to methylphenidate, making animals hyperactivated.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Randall & Hannigan, 1999</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal model of PAE</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">55-0-MPH dose</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">53-4 mg/kg MPH</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">52-8 mg/kg MPH</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">MPH in PAE animals did not produce significant dose-response effects on adult locomotor activity. The low dose group had &lt; D2 binding sites in dorsal and ventral striatum. Effect reversed by MPH.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:7.95pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Persistent changes in the low dose group may reflect persistent changes within the dopaminergic system due to PAE. Authors state results difficult to explain and contrary to typical dose-response effects seen with PAE.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Shen & Choong, 2006</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal model of PAE</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Saline: PAE=27, Con=38;</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">MPH D1: PAE=49, Con=64</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">MPH D7: PAE=27, Con=53;</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">MPH &gt; D30: PAE=52, Con=53</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">MPH treatment to PAE animals resulted in &lt; excitability of the ventral tegmental area dopamine (VTA DA ) neurons.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:3.45pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">VTA DA in response to MPH activity distinctly different in PAE and controls with PAE animals characterized by decreased excitability in the VTA DA neurons.</span></p></td></tr></tbody></table><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><br style="page-break-before:always" clear="all"></span>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<table style="border-bottom:medium none;border-left:medium none;width:649px;border-collapse:collapse;height:628px;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="649">
<tbody>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Thomas et al, 2004</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal model of PAE</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">0</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">18.8 mg/kg choline chloride</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Ss exposed to PAE were significantly more active compared to controls and had a greater number of perseverative errors on a reversal learning task but this was attenuated by choline treatment provided postnatally.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:black 1pt solid;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:3.45pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Choline supplementation provided long-lasting organizational effects in PAE Ss resulting in decreased hyperactivity and improved learning performance.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Thomas et al., 2007</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal model of PAE</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">0</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">10 mg/kg choline chloride</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">50 mg/kg choline chloride</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">100 mg/kg choline chloride</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Females subjects exposed to ethanol were overactive and had spatial learning deficits. These deficits were attenuated with choline supplementation provided postnatally.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:3.45pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Choline supplementation can alter brain development after a history of PAE even when provided postnatally.</span></p></td></tr>
<tr>
<td style="border-bottom:black 1pt solid;border-left:black 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:0.95in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="114">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Marche et al, 2011</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="135">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Animal model of PAE</span></p>
<p style="text-indent:-12.6pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Untreated CON</span></p>
<p style="text-indent:-12.6pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">     </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Untreated PAE</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Fenofibrate CON</span></p>
<p style="text-indent:-9pt;margin-left:12.6pt" class="MsoNormal"><span style="line-height:115%;font-family:symbol;font-size:10pt"><span>·<span style="font:7pt 'times new roman'">   </span></span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Fenofibrate PAE</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:153pt;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="255">
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Hyperactivity and accompanying attention deficit seen in 5<sup>th</sup> week of life in their rat model prevented by administration of fenofibrate for 2 weeks after lactation stopped. Fenofibrate is a lipid regulating agent often used to treat hyperlipidemia. The drug affects nuclear receptors (i.e. peroxisome proliferator-activated receptor-PPAR-alpha). These receptors are in various cell compartments of the brain. These receptors can regulate central dopaminergic and cholinergic pathways.</span></p></td>
<td style="border-bottom:black 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:2.5in;padding-right:5.4pt;border-top:medium none;border-right:black 1pt solid;padding-top:0in" valign="top" width="300">
<p style="margin-left:3.45pt" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Pharmacological Interventions that modify nuclear receptors, such as PPAR-alpha, may be a novel therapeutic approach to deal with behavioral symptoms associated with PAE.</span></p></td></tr></tbody></table>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal" class="MsoBodyText"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="X-NONE"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">3. <span> </span><u>Available Treatments</u></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Recommendations for treatment approaches are available for those who would be recognized with ND-PAE with this new diagnostic category </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(</span><a title="Goodlett, 2005 #4" href="#_enref_78"><span style="color:windowtext;text-decoration:none;text-underline:none">Goodlett, et al., 2005</span></a><span>; </span><a title="Kalberg, 2007 #251" href="#_enref_104"><span style="color:windowtext;text-decoration:none;text-underline:none">Kalberg & Buckley, 2007</span></a><span>; </span><a title="Olson, 2007 #138" href="#_enref_181"><span style="color:windowtext;text-decoration:none;text-underline:none">Olson, et al., 2007</span></a><span>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>Existing treatment approaches have been critically reviewed<span>  </span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(</span><a title="Chandrasena, 2009 #567" href="#_enref_35"><span style="color:windowtext;text-decoration:none;text-underline:none">Chandrasena, Mukherjee, & Turk, 2009</span></a><span>; </span><a title="Hagerman, 1999 #254" href="#_enref_85"><span style="color:windowtext;text-decoration:none;text-underline:none">Hagerman, 1999</span></a><span>; </span><a title="Paley, 2009 #252" href="#_enref_186"><span style="color:windowtext;text-decoration:none;text-underline:none">Paley & O'Connor, 2009</span></a><span>; </span><a title="Peadon, 2009 #253" href="#_enref_187"><span style="color:windowtext;text-decoration:none;text-underline:none">Peadon, Rhys-Jones, Bower, & Elliott, 2009</span></a><span>; </span><a title="Premji, 2007 #255" href="#_enref_192"><span style="color:windowtext;text-decoration:none;text-underline:none">Premji, Benzies, Serrett, & Hayden, 2007</span></a><span>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>Promising approaches to improvement of neurobehavioral outcomes are being explored in animal models and clinical samples </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(</span><a title="Adnams, 2007 #246" href="#_enref_3"><span style="color:windowtext;text-decoration:none;text-underline:none">Adnams et al., 2007</span></a><span>; </span><a title="Coles, 2007 #248" href="#_enref_51"><span style="color:windowtext;text-decoration:none;text-underline:none">Coles, Strickland, Padgett, & Bellmoff, 2007</span></a><span>; </span><a title="Goodlett, 2005 #4" href="#_enref_78"><span style="color:windowtext;text-decoration:none;text-underline:none">Goodlett, et al., 2005</span></a><span>; </span><a title="Kable, 2007 #247" href="#_enref_102"><span style="color:windowtext;text-decoration:none;text-underline:none">Kable, Coles, & Taddeo, 2007</span></a><span>; O'Connor et al., 2006; </span><a title="Olson, 2004 #142" href="#_enref_179"><span style="color:windowtext;text-decoration:none;text-underline:none">Olson, et al., 2004</span></a><span>; </span><a title="Olson, in press #125" href="#_enref_182"><span style="color:windowtext;text-decoration:none;text-underline:none">Olson & Montague, in press</span></a><span>; </span><a title="Olson, 2009 #249" href="#_enref_183"><span style="color:windowtext;text-decoration:none;text-underline:none">Olson, Oti, Gelo, & Beck, 2009</span></a><span>; </span><a title="Thomas, 2009 #250" href="#_enref_244"><span style="color:windowtext;text-decoration:none;text-underline:none">Thomas, Abou, & Dominguez, 2009</span></a><span>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Several lines of animal research suggest the promise of various prenatal and neonatal interventions.<span>  </span>The benefits of prenatal and postnatal treatment with neuroprotective peptides in mitigating the effects of PAE on brain development have been reported (Incenti et al., 2010a, b; Zhou, Fang, & Goodlett, 2008).<span>  </span>Studies have also documented the protective effects of various nutrients (Naseer, Lee, & Kim, 2010; Ojeda et al., 2009; Serrano, Han, Brinez, & Linask, 2010; Summers, Rofe, & Coyle, 2009; Thomas, Abou, & Domnguez, 2009).<span>  </span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Other research has demonstrated positive effects of neonatal handling, postnatal environment enrichment, and rehabilitative training on rats and mice with perinatal alcohol exposure (Guerri et al., 2005; Thomas, Sather, & Whinery, 2008).<span>   </span>This animal research has direct implications for clinical intervention with humans, and pilot studies to examine environmental enrichment and motor training interventions are underway now.</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Studies of treatments for children with PAE have targeted behavioral problems, cognitive and academic skills, and adaptive skills.<span>  </span>Positive effects have been demonstrated in studies utilizing supportive behavioral consultation with parents (see Betrand, 2009), socio-cognitive habilitation to improve math skills (Coles, Kable, & Taddeo, 2009; Kable, Coles, & Taddeo, 2007), language and literacy training (Adnams et al., 2007), rehearsal training to improve working memory (Loomes et al., 2008),<span>  </span>a computer-based intervention to increase fire and street safety skills (Coles, Strickland, Padgett, & Bellmoff, 2007), and a manualized, parent-assisted social skills intervention (O’Connor et al., 2006). </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Community and clinic-based surveys indicate that stimulants are commonly used for children with PAE (O’Malley and Nanson, 2002).<span>  </span>Clinical trials using standard ADHD medications have begun but so far produced mixed results. Two crossover studies utilizing small samples demonstrated positive effects of stimulants on hyperactive symptoms, but not on measures of inattention (Oesterheld et al., 1998; Snyder, Nanson, Snyder, & Block, 1997).<span>  </span>Retrospective studies of medication response among individuals with PAE have also yielded mixed results, with some research finding more positive responses to some stimulant medications than others (O’Malley, Koplin, & Dohner, 2000), or a significant number of side effects (Coe et al., 2001). Most recently, Doig and colleagues </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(</span><a title="Doig, 2008 #187" href="#_enref_64"><span style="color:windowtext;text-decoration:none;text-underline:none">2008</span></a><span>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> reviewed 41 medication trials in a sample of 27 children with PAE and ADHD.<span>  </span>Significant effects were seen on all three domains of the MTA-SNAP-IV, although more children received normalized scores in the hyperactive/impulsive and oppositional/defiant domains than in the inattentive domain.<span>  </span>Collectively, these suggest that inattentive symptoms may not be effectively ameliorated by psychostimulant medications. Psychostimulant medications have also not been found to be as beneficial as neuroleptics in facilitating response to cognitive behavioral treatments </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>(</span><a title="Frankel, 2006 #188" href="#_enref_71"><span style="color:windowtext;text-decoration:none;text-underline:none">Frankel, Paley, Marquardt, & O'Connor, 2006</span></a><span>)</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>Clearly larger samples and more intensive research attention is needed, which would be facilitated by recognition of the ND-PAE diagnostic category.</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">4.<span>  </span><u>Meets Criteria for a Mental (Psychiatric) Diagnosis</u></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">As outlined in the current memorandum and associated appendices, the proposed new condition, ND-PAE, meets the criteria for a mental (psychiatric) disorder as delineated in Stein et al. (2010). <span> </span>The condition is a behavioral, psychological syndrome that occurs in an individual. It creates clinically significant distress and impairment, and is not merely an expectable response to stress or loss— or a culturally sanctioned response to a particular event— nor is it the result of social deviance or societal conflicts. ND-PAE is associated with psychobiological dysfunction. With regard to other considerations as presented by Stein et al. (2010), the current document and associated appendices summarize data on validity and clinical utility. These materials also consider differentiation from “nearest” neighbors, specifically ADHD.</span></p></div><div id="DSM_TabContent_Severity"><font size="2" face="Arial">Severity criteria for this disorder have not been proposed.</font></div><div id="DSM_TabContent_DSM-IV"><div style="display:block" id="DSM_TabContent_DSM-IV"><span style="font-family:'arial', 'sans-serif';font-size:8pt"><span style="font-family:'arial', 'sans-serif';font-size:10pt">This disorder is not listed in DSM-IV; therefore, DSM-IV criteria for this disorder do not exist.</span></span></div></div></td></tr></table></td></tr></table><table cellspacing="0" cellpadding="4" border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr></tr></table></div></td>
			</tr>
		</table></td>
	</tr>
</table>
	</div>
	<div id="DSM_RightCol">
		<div id="DSM_int_topRight">	
			<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ3" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="29710d0b-d267-4d1e-8295-7591f28eec41" haspers="false" id="WebPartWPQ3" width="100%" class="ms-WPBody" allowdelete="false" style=""><div id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41">
        <table id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1" cellspacing="0" cellpadding="0" border="0">
						<tr>
							<td>
                <table border="0" cellpadding="1" cellspacing="0" style="border-collapse: collapse">
                    <tr>
                        <td>
                            <table border="0" cellpadding="0">
                                <tr valign="top">
                                    <td align="left" colspan="2" valign="top">
                                        <h2>Participate</h2><!--Login to comment on the DSM-5-->
                                    </td>
                                </tr>
                                <tr valign="top">
                                    <td align="right">
                                        <label for="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_UserName" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_UserNameLabel">User Name:</label></td>
                                    <td>
                                        <input name="ctl00$m$g_29710d0b_d267_4d1e_8295_7591f28eec41$ctl00$LoginView1$Login1$UserName" type="text" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_UserName"/>
                                    </td>
                                </tr>
                                <tr valign="top">
                                    <td align="right">
                                        <label for="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_Password" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_PasswordLabel">Password:</label></td>
                                    <td>
                                        <input name="ctl00$m$g_29710d0b_d267_4d1e_8295_7591f28eec41$ctl00$LoginView1$Login1$Password" type="password" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_Password"/>                                        
                                    </td>
                                </tr>
                                <tr valign="top">
                                    <td></td>                                
                                    <td align="left">
                                        <input type="submit" name="ctl00$m$g_29710d0b_d267_4d1e_8295_7591f28eec41$ctl00$LoginView1$Login1$LoginButton" value="Login" id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_LoginButton"/>
                                    </td>
                                    <td></td>
                                </tr>
                                <tr valign="top" align="left">
                                    <td align="center" colspan="2" style="color: red">
                                    </td>
                                </tr>
                                <tr align="left">
                                    <td align="left" colspan="2">                                        
    <a id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_hlRegistration" href="../../Pages/Registration.html">
      New User? Register Now
    </a>
                                    </td>
                                </tr>
                                <tr align="left">
                                    <td align="left" colspan="2">                                        
    <a id="ctl00_m_g_29710d0b_d267_4d1e_8295_7591f28eec41_ctl00_LoginView1_Login1_hlForgotPassword" href="../../Pages/ForgotPassword.html">
      Forgot Password?
    </a>
                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>
                </table>
            </td>
						</tr>
					</table>
				</div></div></td>
			</tr>
		</table></td>
	</tr>
</table>	
		</div>
		<div id="DSM_int_btmRight">
			<div id="ctl00_PlaceHolderMain_ctl00__ControlWrapper_RichHtmlField" style="display:inline"></div>						
			<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ1" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="8bd325df-1ef5-4c59-9cf9-133a68ebd1c0" haspers="false" id="WebPartWPQ1" width="100%" allowdelete="false" allowexport="false" style=""><table width="100%" cellspacing="0" cellpadding="0" border="0"><script>
ctx = new ContextInfo();
ctx.listBaseType = 0;
ctx.listTemplate = 103;
ctx.listName = "{B800DB4C-1750-45F8-87A7-8DC7A15C16A1}";
ctx.view = "{8BD325DF-1EF5-4C59-9CF9-133A68EBD1C0}";
ctx.listUrlDir = "\u002fProposedRevisions\u002fLists\u002fRelated\u002520Links";
ctx.HttpPath = "\u002fProposedRevisions\u002f_vti_bin\u002fowssvr.dll?CS=65001";
ctx.HttpRoot = "https:\u002f\u002f\u002fweb\u002f20121019205302\u002fhttp:\u002f\u002fwww.dsm5.org\u002fProposedRevisions";
ctx.imagesPath = "\u002f_layouts\u002fimages\u002f";
ctx.PortalUrl = "";
ctx.SendToLocationName = "";
ctx.SendToLocationUrl = "";
ctx.RecycleBinEnabled = -1;
ctx.OfficialFileName = "";
ctx.WriteSecurity = "1";
ctx.SiteTitle = "Proposed Revisions";
ctx.ListTitle = "Proposed Revisions Related Links";
if (ctx.PortalUrl == "") ctx.PortalUrl = null;
ctx.displayFormUrl = "\u002fProposedRevisions\u002fLists\u002fRelated\u002520Links\u002fDispForm.aspx";
ctx.editFormUrl = "\u002fProposedRevisions\u002fLists\u002fRelated\u002520Links\u002fEditForm.aspx";
ctx.isWebEditorPreview = 0;
ctx.ctxId = 1;
g_ViewIdToViewCounterMap[ "{8BD325DF-1EF5-4C59-9CF9-133A68EBD1C0}" ]= 1;
ctx.CurrentUserId = -1;
ctx1 = ctx;
</script><tr><td><table id="{B800DB4C-1750-45F8-87A7-8DC7A15C16A1}-{8BD325DF-1EF5-4C59-9CF9-133A68EBD1C0}" summary="Proposed Revisions Related Links" o:webquerysourcehref="http://www.dsm5.org/ProposedRevisions/_vti_bin/owssvr.dll?CS=65001&amp;XMLDATA=1&amp;RowLimit=0&amp;List={B800DB4C-1750-45F8-87A7-8DC7A15C16A1}&amp;View={8BD325DF-1EF5-4C59-9CF9-133A68EBD1C0}" class="ms-summarycustombody" style="margin-bottom: 5px;" cellpadding="0" cellspacing="0" border="0">
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="http://www.psych.org/">American Psychiatric Association</a>
                            </td>
                        </tr>
                    </table></td></tr></table><table id="ECBItems" style="display:none" height="0" width="0"><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XsnLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xsn</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.2</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.3</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/ProposedRevisions/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.4</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/ProposedRevisions/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/ProposedRevisions/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>255</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/ProposedRevisions/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>256</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/ProposedRevisions/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>256</td></tr></table></div></td>
			</tr>
		</table></td>
	</tr>
</table>						
		</div>						
	</div>	
	<div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="1" height="1" alt=""/></div>	
<!---- end MAIN CONTENT AREA ---->
			</div>
			<div id="DSM_Footer">
				<p class="DSM_Tagline">Representing 36,000 physician leaders in mental health.</p>
				<p>© <strong>2012 American Psychiatric Association.</strong> All Rights Reserved.<br/>
				Use of all Materials on this Website is subject to the <a href="../../Pages/PermissionsPolicy.html">APA Permissions Policy</a> and <a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use.</a><br/>
				<br/>  
				1000 Wilson Boulevard, Suite 1825, Arlington, Va. 22209-3901<br/>
				phone: 703-907-7300 <a href="mailto:apa@psych.org?subject=DSM5:">email: apa@psych.org</a></p>
				<div class="DSM_SocialLinks">
	 				<table>
	 					<tr>
	 						<td>Find us on:</td>
							<td><a href="http://www.facebook.com/pages/DSM-5-Diagnostic-and-Statistical-Manual-of-Mental-Disorders/260197062886" target="_blank"><img src="../../Style Library/DSM_Images/facebook.gif" width="58" height="15" alt="Find us on Facebook"/></a></td>
							<td><a href="http://twitter.com/dsm5" target="_blank"><img src="../../Style Library/DSM_Images/twitter.jpg" width="60" height="20" alt="Find us on Twitter"/></a></td>
						</tr>
	 				</table>
				</div>
				<p><a href="../../pages/Contactus.html">Contact Us For Help</a></p>
			</div>		
		</div>
<!-- end MAIN LAYOUT -->
<!-- begin EDITOR POSITIONING DIV -->
	<div id="ctl00_MSO_ContentDiv" class="SP_editorPosition">&nbsp;</div>
<!-- end EDITOR POSITIONING DIV -->
<!-- begin HIDDEN MASTER PAGE ELEMENTS -->
	<div style="display:none">
			<div class="breadcrumb">
				<span id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath"><a href="#ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"><img alt="Skip Navigation Links" height="0" width="0" src="../../WebResource.axd_d_nmHMzpcb8opA4_TBGiLLxg2_t_633965588901821931.jpg" border="0"/></a><span><a class="ms-sitemapdirectional" href="/">Home</a></span><span> &gt; </span><span><a title="Proposed Revisions" class="ms-sitemapdirectional" href="../../ProposedRevisions/Pages/Default.html">Proposed Revisions</a></span><span> &gt; </span><span class="breadcrumbCurrent">Proposed Revision</span><a id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"></a></span>
			</div>
	</div>
<!-- end HIDDEN MASTER PAGE ELEMENTS -->
<script type="text/javascript">
//<![CDATA[
var __wpmExportWarning='This Web Part Page has been personalized. As a result, one or more Web Part properties may contain confidential information. Make sure the properties contain information that is safe for others to read. After exporting this Web Part, view properties in the Web Part description file (.WebPart) by using a text editor such as Microsoft Notepad.';var __wpmCloseProviderWarning='You are about to close this Web Part.  It is currently providing data to other Web Parts, and these connections will be deleted if this Web Part is closed.  To close this Web Part, click OK.  To keep this Web Part, click Cancel.';var __wpmDeleteWarning='You are about to permanently delete this Web Part.  Are you sure you want to do this?  To delete this Web Part, click OK.  To keep this Web Part, click Cancel.';var zz1_TopNavigationMenu_Data = new Object();
zz1_TopNavigationMenu_Data.disappearAfter = 500;
zz1_TopNavigationMenu_Data.horizontalOffset = 0;
zz1_TopNavigationMenu_Data.verticalOffset = 0;
zz1_TopNavigationMenu_Data.hoverClass = 'zz1_TopNavigationMenu_15 DSM_dynamicNavHover';
zz1_TopNavigationMenu_Data.hoverHyperLinkClass = 'zz1_TopNavigationMenu_14 DSM_dynamicNavHover';
zz1_TopNavigationMenu_Data.staticHoverClass = 'zz1_TopNavigationMenu_13 DSM_staticNavHover';
zz1_TopNavigationMenu_Data.staticHoverHyperLinkClass = 'zz1_TopNavigationMenu_12 DSM_staticNavHover';
if (typeof(overrideMenu_HoverStatic) == 'function' && typeof(Menu_HoverStatic) == 'function')
{
_spBodyOnLoadFunctionNames.push('enableFlyoutsAfterDelay');
Menu_HoverStatic = overrideMenu_HoverStatic;
}
var flyoutsAllowed = false;
function enableFlyoutsAfterDelay()
{
setTimeout('flyoutsAllowed = true;', 50);
}
function overrideMenu_HoverStatic(item)
{
if (!flyoutsAllowed || (document.readyState != null && document.readyState != 'complete'))
{
setTimeout(delayMenu_HoverStatic(item), 50);
}
else
{
// this code is the default ASP.NET implementation of Menu_HoverStatic
var node = Menu_HoverRoot(item);
var data = Menu_GetData(item);
if (!data) return;
__disappearAfter = data.disappearAfter;
Menu_Expand(node, data.horizontalOffset, data.verticalOffset);
}
}
function delayMenu_HoverStatic(item)
{
return (function()
{
overrideMenu_HoverStatic(item);
});
}
//]]>
</script>
</form>
  <!-- Google Code -->
  <script type="text/javascript">
  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-16139255-17']);
  _gaq.push(['_setDomainName', '.dsm5.org']);
  _gaq.push(['_trackPageview']);
  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + 
'.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();
</script>
</body>
</html>